MedPath
NMPA Approval

Mogamulizumab Injection

国药准字SJ20220018

October 11, 2022

Drug Information

莫格利珠单抗注射液

惠尔金

注射剂

西林瓶装注射剂型:20mg(5ml)/瓶

生物制品

October 11, 2022

October 10, 2027

Company Information

Applicant Company

1-9-2 Otemachi, Chiyoda-ku, Tokyo, Japan

Manufacturing Company

toyobo company limited, otsu pharmaceutical plant

1-1 Katata-2-Chome, Otsu-Shi, Shiga, 520-0292, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.